Myocarditis, an inflammatory condition affecting the myocardium (heart muscle), is often caused by viral infections and represents a significant cardiovascular health concern. Among the viruses implicated in myocarditis, enteroviruses, adenoviruses, and parvovirus B19 are common culprits. Viral myocarditis can result from direct viral invasion or as an immune response to the infection. The clinical presentation of viral myocarditis varies, ranging from mild flu-like symptoms to severe heart failure. Diagnosing myocarditis involves a combination of clinical evaluation, cardiac imaging, and laboratory tests. Endomyocardial biopsy may be performed in severe cases for definitive diagnosis. Treatment includes supportive care, antiviral medications, and immunosuppressive therapy in certain cases. Preventing viral myocarditis involves practicing good hygiene, vaccination against preventable viral infections, and managing underlying conditions that may predispose individuals to the development of myocarditis. Research into the pathogenesis and treatment options for viral myocarditis continues to advance our understanding of this complex cardiovascular infection, offering hope for improved outcomes and therapies in the future.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation